PitchSend

Informa Results Presentation Deck

Accelerating Shareholder Returns ● ● ● Return up to £1bn of embedded value through 2022/2023 Pharma Investment divestment for £1.9bn-expected post-tax proceeds of c£1.5bn Share Buyback Programme launched on 14 February 2022 Tranche 1 completed: 17m shares repurchased and cancelled at average price of 587p £100m of value returned to Shareholders Tranche 2 underway: Further £200m committed to buybacks Total capital returns committed to date of £300m Ordinary dividend to resume from interim dividend 2022 2021 Full-Year Results Presentation £300m of Buyback Programme now committed informa gap¹> £100m Capital returned to date £200m Additional capital returns committed 17m Shares cancelled 27

View entire presentation